.svg){kind=small}
Sep-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Avexia has shown a consistent performance in the Illinois market, particularly in the Capsules and Topical categories. In Illinois, Avexia has maintained a steady second-place rank for Capsules from June to September 2024, indicating a strong foothold in this category. Meanwhile, in the Topical category, Avexia has consistently held the top position, demonstrating its dominance. In Concentrates, Avexia has improved its ranking from 21st in June and July to 15th by September, suggesting a positive trend in this segment. This upward movement in Concentrates is notable, especially when considering the competitive landscape of this category.
In Massachusetts and Maryland, Avexia's performance has been mixed. In Massachusetts, Avexia was absent from the top 30 in the Topical category in June but made a significant entry at 6th place in July, maintaining a strong presence thereafter. However, in the Concentrates category, Avexia did not rank in the top 30 in July and September, which could indicate challenges in gaining traction. Conversely, in Maryland, Avexia has consistently ranked first in the Topical category, underscoring its strong market presence. However, its absence from the top 30 in Concentrates in June and September suggests areas for potential growth. In Ohio, Avexia has shown resilience in the Topical category, climbing from 4th in June to 2nd by September, reflecting a positive upward trend.
Competitive Landscape
In the Illinois Topical category, Avexia has consistently maintained its top rank from June to September 2024, demonstrating a strong market presence and consumer preference. Despite a slight fluctuation in sales figures over these months, Avexia's leadership position remains unchallenged. In contrast, Doctor Solomon's has shown some variability, dropping to third place in August before regaining its second-place position in September. This indicates potential volatility in consumer loyalty or market strategy effectiveness. Meanwhile, Pure Essentials has consistently ranked fourth, with minor fluctuations in sales, suggesting a stable but less dominant market position. These dynamics highlight Avexia's robust brand strength in the Illinois Topical market, as competitors struggle to close the gap in both rank and sales.
Notable Products
In September 2024, the top-performing product from Avexia was the CBD/THC 1:1 Harmony Pain Relief Balm (100mg CBD, 100mg THC, 2oz), maintaining its first-place ranking consistently since June. This product achieved notable sales of 11,160 units, showcasing its continued popularity. The CBD/THC 4:1 Relief Tablets 40-Pack (400mg CBD, 100mg THC) also retained its position in second place, reflecting stable demand across the months. The CBN/CBD/THC 1:1:1 Comfort Tablets 40-Pack (100mg CBN, 100mg CBD, 100mg THC) held steady at third place, while the CBD/THC 1:1 Harmony Micro-Dosed Tablets 40-Pack (100mg CBD, 100mg THC) consistently ranked fourth. The CBD/THC 1:1 Harmony Pain Relief Lotion (295mg CBD, 314mg THC) has maintained its fifth position since its entry into the rankings in August, indicating a positive reception.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
